A normal genetic variation modulates synaptic MMP-9 protein levels and the 
severity of schizophrenia symptoms

Lepeta, Katarzyna; Purzycka, Katarzyna J.; Pachulska-Wieczorek, Katarzyna; Mitjans, Marina; Begemann, Martin; Vafadari, Behnam; Bijata, Krystian; Adamiak, Ryszard W.; Ehrenreich, Hannelore; Dziembowska, Magdalena; Kaczmarek, Leszek

doi:10.15252/emmm.201707723

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

A normal genetic variation modulates synaptic MMP-9 protein levels and the severity of schizophrenia symptoms

MPS-Authors

/persons/resource/persons182304

Mitjans, Marina
Clinical neuroscience, Max Planck Institute of Experimental Medicine, Max Planck Society;

/persons/resource/persons182563

Begemann, Martin
Clinical neuroscience, Max Planck Institute of Experimental Medicine, Max Planck Society;

/persons/resource/persons182138

Ehrenreich, Hannelore
Clinical neuroscience, Max Planck Institute of Experimental Medicine, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

Lepeta_17.pdf
(Any fulltext), 2MB

Supplementary Material (public)

There is no public supplementary material available

Citation

Lepeta, K., Purzycka, K. J., Pachulska-Wieczorek, K., Mitjans, M., Begemann, M., Vafadari, B., et al. (2017). A normal genetic variation modulates synaptic MMP-9 protein levels and the severity of schizophrenia symptoms. EMBO Molecular Medicine, 9(8), 1100-1116. doi:10.15252/emmm.201707723.

Cite as: https://hdl.handle.net/11858/00-001M-0000-002D-C4A3-0

Abstract

There is no abstract available